Bristol-Myers New R&D Chief Plans to Keep Focus on Cancer

Bristol-Myers Squibb Co. will stay focused on developing new cancer medicines that use the body’s own immune system to fight the disease, the company’s new head of research and development said today.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.